My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 245

    1.

    Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia.

    Ishii H, Ichimiya S, Kanashiro M, Amano T, Matsubara T, Murohara T.

    Diabetes Care. 2006 Feb;29(2):202-6.PMID: 16443860 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.

    Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T.

    Circulation. 2005 Aug 30;112(9):1284-8. Epub 2005 Aug 22.PMID: 16116055 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Suppressive effect of nicorandil in ventricular arrhythmias after reperfusion therapy in patients with acute myocardial infarction]

    Hara H, Horinaka S, Yabe A, Yagi H, Tsuboko Y, Yoshida K, Iemura T, Matsuoka H.

    J Cardiol. 2007 Mar;49(3):135-41. Japanese. PMID: 17444139 [PubMed - indexed for MEDLINE]Related articles

    4.

    Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.

    Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H, Kitamura S; J-WIND investigators.

    Lancet. 2007 Oct 27;370(9597):1483-93. Erratum in: Lancet. 2008 Dec 22;370(9605):2102. PMID: 17964349 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.

    Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hori M, Higashino Y, Fujii K, Minamino T.

    J Am Coll Cardiol. 1999 Mar;33(3):654-60.PMID: 10080465 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.

    Ishii H, Ichimiya S, Kanashiro M, Amano T, Ogawa Y, Mitsuhashi H, Sakai S, Uetani T, Murakami R, Naruse K, Murohara T, Matsubara T.

    Am J Cardiol. 2007 May 1;99(9):1203-7. Epub 2007 Mar 16.PMID: 17478142 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.

    Ishii H, Ichimiya S, Kanashiro M, Aoyama T, Ogawa Y, Murakami R, Amano T, Naruse K, Matsubara T, Murohara T.

    Clin Ther. 2006 Nov;28(11):1812-9.PMID: 17213001 [PubMed - indexed for MEDLINE]Related articles

    8.

    Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome.

    Claeys MJ, Bosmans J, Veenstra L, Jorens P, De RaedtH, Vrints CJ.

    Circulation. 1999 Apr 20;99(15):1972-7.PMID: 10209000 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Intravenous nicorandil can reduce the occurrence of ventricular fibrillation and QT dispersion in patients with successful coronary angioplasty in acute myocardial infarction.

    Ueda H, Nakayama Y, Tsumura K, Yoshimaru K, Hayashi T, Yoshikawa J.

    Can J Cardiol. 2004 May 1;20(6):625-9.PMID: 15152293 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty.

    Yip HK, Wu CJ, Chang HW, Yang CH, Yu TH, Chen YH, Hang CL.

    Chest. 2005 May;127(5):1491-7.PMID: 15888819 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.

    Ono H, Osanai T, Ishizaka H, Hanada H, Kamada T, Onodera H, Fujita N, Sasaki S, Matsunaga T, Okumura K.

    Am Heart J. 2004 Oct;148(4):E15.PMID: 15459610 [PubMed - indexed for MEDLINE]Related articles

    12.

    Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by a K-ATP channel opener (J-WIND-KATP).

    Minamino T, Jiyoong K, Asakura M, Shintani Y, Asanuma H, Kitakaze M; J-WIND Investigators.

    Circ J. 2004 Feb;68(2):101-6.PMID: 14745142 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty.

    Uyarel H, Uzunlar B, Unal Dayi S, Tartan Z, Samur H, Kasikcioglu H, Akgul O, Simsek D, Erdem I, Okmen E, Cam N.

    Cardiology. 2006;105(3):168-75. Epub 2006 Feb 13.PMID: 16479104 [PubMed - indexed for MEDLINE]Related articles

    14.

    The influence of admission glucose on epicardial and microvascular flow after primary angioplasty.

    Shen XH, Jia SQ, Li HW.

    Chin Med J (Engl). 2006 Jan 20;119(2):95-102.PMID: 16454990 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparison between nicorandil and magnesium as an adjunct cardioprotective agent to percutaneous coronary intervention in acute anterior myocardial infarction.

    Nameki M, Ishibashi I, Miyazaki Y, Sakai Y, Namikawa S, Kuriyama N, Komiyama N, Tsunoda K, Masuda Y, Komuro I.

    Circ J. 2004 Mar;68(3):192-7.PMID: 14993771 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.

    Lim SY, Bae EH, Jeong MH, Kang DG, Lee YS, Kim KH, Lee SH, Yoon KH, Hong SN, Park HW, Hong YJ, Kim JH, Kim W, Ahn YK, Cho JG, Park JC, Kang JC.

    Circ J. 2004 Oct;68(10):928-32.PMID: 15459466 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction.

    Sugimoto K, Ito H, Iwakura K, Ikushima M, Kato A, Kimura R, Tanaka K, Masuyama T, Ogihara T, Kawano S, Fujii K.

    Circ J. 2003 Apr;67(4):295-300.PMID: 12655158 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

    Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF.

    Coron Artery Dis. 2008 Jun;19(4):271-7.PMID: 18480672 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nicorandil suppressed myocardial injury after percutaneous coronary intervention.

    Isono T, Kamihata H, Sutani Y, Motohiro M, Yamamoto S, Kyoui S, Iharada Y, Kurimoto K, Hara K, Takahashi H, Iwasaka T.

    Int J Cardiol. 2008 Jan 11;123(2):123-8. Epub 2007 Mar 8.PMID: 17346816 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.

    Kurihara H, Matsumoto S, Tamura R, Yachiku K, Nakata A, Nakagawa T, Yoshino T, Matsuyama T.

    Am Heart J. 2004 Apr;147(4):E14.PMID: 15077097 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity